Aimei Health Technology Co., Ltd - Ordinary Share (AFJK) Stock

About Aimei Health Technology Co., Ltd - Ordinary Share

Aimei Health Technology Co., Ltd - Ordinary Share is led by CEO Junheng Xie, employs 2 people, headquartered in US, publicly traded since 2024.

Aimei Health Technology Co., Ltd - Ordinary Share (AFJK) stock trades at $12.06 with a market capitalization of $38.19M. The stock is valued at a price-to-earnings (P/E) ratio of 177.57, price-to-book of 1.57, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $6.75 and $130.37, and currently trades 90.7% below its 52-week high.

On profitability, Aimei Health Technology Co., Ltd - Ordinary Share generates a return on equity (ROE) of 2.49%, return on capital employed of -7.31%.

Aimei Health Technology Co., Ltd - Ordinary Share by the numbers, 2023–2025

Between 2023 and 2025 Aimei Health Technology Co., Ltd - Ordinary Share reported revenue of $0 rising to $0. Compounded, revenue has grown —% a year over five years, —% over three, —% over the last twelve months. Net profit was $1.0M in 2025.

On a trailing twelve-month basis to Jun '26, revenue is $0 and net profit $0.

Borrowings stand at $2.0M, cash from operations was $-1.0M in the latest year, positive in 0 of the last 3.

Return on equity has averaged 5.6% over five years, and was 12.5% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Aimei Health Technology Co., Ltd - Ordinary Share (AFJK) — frequently asked questions